# Financial Disclosure by Clinical Investigators:  Guidance for Clinical Investigators, Industry,and FDA Staff - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/financial-disclosure-by-clinical-investigators-guidance-for-clinical-investigators-industryand-fda-staff/a2fdcaf8-673b-4e11-9017-f37e4d719af8

> FDA guidance document: Financial Disclosure by Clinical Investigators:  Guidance for Clinical Investigators, Industry,and FDA Staff. Issue date: February 01, 2013. Get complete insights and analysis.

---

## Details

- Title: Financial Disclosure by Clinical Investigators:  Guidance for Clinical Investigators, Industry,and FDA Staff
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2013-02-01
- Last Changed: 2023-08-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-0742">FDA-1999-D-0742</a>

## Related Documents

- [Considerations When Transferring Clinical Investigation Oversight to Another IRB:  Guidance for IRBs, Clinical Investigators, and Sponsors](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-when-transferring-clinical-investigation-oversight-to-another-irb-guidance-for-irbs-clinical-investigators-and-sponsors/fe8296e5-3ca7-4209-9920-27aa4635ee35)
- [Electronic Source Data in Clinical Investigations:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/electronic-source-data-in-clinical-investigations-guidance-for-industry/6d72d592-c70b-47f5-810c-0542a685c1b5)
- [Adverse Event Reporting to IRBs — Improving Human Subject Protection:  Guidance for Clinical Investigators, Sponsors, and IRBs](https://www.globalkeysolutions.net/guidances/guidance-document/adverse-event-reporting-to-irbs-improving-human-subject-protection-guidance-for-clinical-investigators-sponsors-and-irbs/8b4e7049-16fc-40f8-b121-81ece765bc26)